BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Expanded Collaboration Between GeneData (USA), Inc. And ALTANA Pharma (AAA) Creates Novel Framework For Drug Discovery


10/19/2005 5:08:51 PM

BASEL, Switzerland, June 29 /PRNewswire/ -- Computational biology company Genedata today announces the global expansion of their collaboration with ALTANA Pharma to provide enterprise-wide scientific computing infrastructure for ALTANA's research programs in Constance, Germany and in Waltham, Massachusetts.

"With Genedata we gain valuable bioinformatics expertise managed according to a proven collaborative framework," says Vice President of Discovery Research Dr. Ulrich Thibaut.

Dr. Thibaut oversaw signing of the original license for Genedata's scientific computing platform five years ago. "Genedata has brought together and enhanced the best aspects of our research programs on each side of the Atlantic."

"We are pleased that ALTANA sees the value of our collaboration to their research efforts," says Othmar Pfannes, Ph.D., CEO of Genedata. "The product of our work so far is a computa-tional platform tailored to ALTANA's research needs. Today's announcement signals ALTANA's ongoing endorsement of our approach to a fruitful partnership in drug discovery." The collaboration spans ALTANA's research in target identification and validation, and lead discovery.

Target validation is a major focus at the ALTANA Research Institute (ARI) in Waltham.

Dr. Klaus Melchers, ARI's Vice President and Chief Operating Officer describes Genedata's work there. "With Genedata's platform we have a unified computational system that facilitates data and result sharing between our research sites. Genedata's computational scientists are based on both sides of the Atlantic to ensure its smooth operation and to evolve the platform according to our needs."

Genedata's work at each ALTANA research site embodies a unique approach to meeting specific needs in computer supported drug discovery and development. Whether identifying and validating targets or exploring potential lead candidates, results are placed in a rich biological context of structured and high quality proprietary and public knowledge and analysed using Genedata's proprietary algorithms. Tied with the expertise of its global team of cross-discipline scientists Genedata's computational platform constitutes a high power, high-throughput solution for the innovative leaders in drug discovery.

http://www.genedata.com/

http://www.ari.altanapharma.com/

Genedata AG

CONTACT: Genedata AG, Dr. Andreas Hohn, Business Development, Phone+41-61-697-700, Fax +41-61-697-7244, Andreas.Hohn@genedata.com.ALTANA Research Institute, Dr. Klaus Melchers, Vice Presidentand Chief Operating, Officer of ARI, Phone +1-781-290-2523, Fax+1-781-890-4132, klaus.melchers@ari.altanapharma.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES